$3.06 Billion is the total value of BRAIDWELL LP's 82 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 75.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | GUARDANT HEALTH INCnote 11/1 | $193,131,609 | +14.4% | 268,252,000 | +7.3% | 6.31% | +13.3% | |
| Buy | NOVOCURE LTDnote 11/0 | $118,179,303 | +1.2% | 135,834,000 | +1.1% | 3.86% | +0.3% | |
| New | ASCENDIS PHARMA A/Snote 2.250% 4/0 | $113,150,000 | – | 124,000,000 | +100.0% | 3.70% | – | |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $88,016,037 | +13.4% | 933,362 | +21.7% | 2.88% | +12.3% |
| PCVX | Buy | VAXCYTE INC | $86,014,309 | +73.9% | 1,722,353 | +30.5% | 2.81% | +72.2% |
| ALGN | Buy | ALIGN TECHNOLOGY INC | $79,225,969 | +14.5% | 224,030 | +8.2% | 2.59% | +13.4% |
| NTRA | Buy | NATERA INC | $56,097,730 | +2.9% | 1,152,851 | +17.4% | 1.83% | +1.9% |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $51,341,580 | +2.5% | 3,646,419 | +12.5% | 1.68% | +1.6% |
| Buy | NUVASIVE INCnote 0.375% 3/1 | $50,067,315 | +54.2% | 55,323,000 | +50.9% | 1.64% | +52.8% | |
| IRTC | Buy | IRHYTHM TECHNOLOGIES INC | $49,923,066 | -11.4% | 478,557 | +5.4% | 1.63% | -12.2% |
| Buy | DICE THERAPEUTICS INC | $47,849,200 | +69.6% | 1,029,901 | +4.6% | 1.56% | +67.9% | |
| KROS | New | KEROS THERAPEUTICS INC | $45,960,496 | – | 1,143,865 | +100.0% | 1.50% | – |
| NVRO | Buy | NEVRO CORP | $45,155,275 | -23.5% | 1,776,368 | +8.8% | 1.48% | -24.2% |
| MRUS | Buy | MERUS N V | $40,631,455 | +49.9% | 1,543,162 | +4.8% | 1.33% | +48.5% |
| DAWN | Buy | DAY ONE BIOPHARMACEUTICALS I | $40,140,047 | -5.0% | 3,361,813 | +6.4% | 1.31% | -5.8% |
| BSX | New | BOSTON SCIENTIFIC CORP | $38,785,235 | – | 717,050 | +100.0% | 1.27% | – |
| Buy | BRIDGEBIO PHARMA INCnote 2.250% 2/0 | $38,552,328 | +40.8% | 62,294,000 | +47.3% | 1.26% | +39.5% | |
| Buy | PARAGON 28 INC | $37,894,804 | +102.0% | 2,136,122 | +94.4% | 1.24% | +100.0% | |
| AXNX | Buy | AXONICS INC | $28,959,232 | +218.4% | 573,791 | +244.2% | 0.95% | +215.3% |
| VRDN | New | VIRIDIAN THERAPEUTICS INC | $28,697,877 | – | 1,206,300 | +100.0% | 0.94% | – |
| IMCR | Buy | IMMUNOCORE HLDGS PLCads | $28,062,899 | +33.2% | 468,027 | +9.8% | 0.92% | +31.9% |
| ALEC | Buy | ALECTOR INC | $24,829,203 | +25.1% | 4,131,315 | +28.8% | 0.81% | +23.8% |
| ANAB | Buy | ANAPTYSBIO INC | $23,480,964 | +10.9% | 1,154,423 | +18.6% | 0.77% | +9.9% |
| Buy | ILLUMINA INCnote 8/1 | $22,599,467 | +1977.7% | 22,645,000 | +104.0% | 0.74% | +1950.0% | |
| MRVI | New | MARAVAI LIFESCIENCES HLDGS I | $22,432,421 | – | 1,804,700 | +100.0% | 0.73% | – |
| CGEM | New | CULLINAN ONCOLOGY INC | $20,539,387 | – | 1,908,865 | +100.0% | 0.67% | – |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $19,654,835 | +21.2% | 2,791,880 | +43.5% | 0.64% | +20.0% |
| CMPX | Buy | COMPASS THERAPEUTICS INC | $18,934,588 | +78.3% | 5,954,273 | +83.3% | 0.62% | +76.9% |
| RAPT | New | RAPT THERAPEUTICS INC | $18,408,280 | – | 984,400 | +100.0% | 0.60% | – |
| VIR | Buy | VIR BIOTECHNOLOGY INC | $17,871,307 | +27.1% | 728,549 | +20.6% | 0.58% | +25.9% |
| TMO | New | THERMO FISHER SCIENTIFIC INC | $14,243,775 | – | 27,300 | +100.0% | 0.46% | – |
| RYTM | New | RHYTHM PHARMACEUTICALS INC | $13,902,505 | – | 843,087 | +100.0% | 0.45% | – |
| New | INTEGRA LIFESCIENCES HLDGS Cnote 0.500% 8/1 | $13,311,000 | – | 14,500,000 | +100.0% | 0.44% | – | |
| DHR | New | DANAHER CORPORATION | $13,296,000 | – | 55,400 | +100.0% | 0.43% | – |
| RGEN | New | REPLIGEN CORP | $13,014,320 | – | 92,000 | +100.0% | 0.42% | – |
| REPL | Buy | REPLIMUNE GROUP INC | $11,320,214 | +770.2% | 487,520 | +561.8% | 0.37% | +760.5% |
| New | ACELYRIN INC | $10,450,000 | – | 500,000 | +100.0% | 0.34% | – | |
| GH | New | GUARDANT HEALTH INC | $9,666,000 | – | 270,000 | +100.0% | 0.32% | – |
| SGEN | New | SEAGEN INC | $8,178,973 | – | 42,497 | +100.0% | 0.27% | – |
| AGEN | New | AGENUS INC | $7,516,688 | – | 4,697,930 | +100.0% | 0.25% | – |
| New | CUTERA INCnote 2.250% 6/0 | $7,202,906 | – | 11,500,000 | +100.0% | 0.24% | – | |
| ATEC | New | ALPHATEC HLDGS INC | $457,249 | – | 25,431 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GUARDANT HEALTH INC | 7 | Q2 2024 | 6.9% |
| NOVOCURE LTD | 7 | Q2 2024 | 4.3% |
| BRIDGEBIO PHARMA INC | 7 | Q2 2024 | 5.1% |
| XENON PHARMACEUTICALS INC | 7 | Q2 2024 | 3.1% |
| VAXCYTE INC | 7 | Q2 2024 | 3.0% |
| NUVASIVE INC | 7 | Q2 2024 | 3.5% |
| ALPHATEC HLDGS INC | 7 | Q2 2024 | 3.6% |
| GLAUKOS CORP | 7 | Q2 2024 | 3.0% |
| ALIGN TECHNOLOGY INC | 7 | Q2 2024 | 2.6% |
| IRHYTHM TECHNOLOGIES INC | 7 | Q2 2024 | 2.2% |
View BRAIDWELL LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
View BRAIDWELL LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.